RL1
ACCDIS > RL1
13
Ago
Potential adverse cardiac remodelling in highly trained athletes: still unknown clinical significance. Eur J Sport Sci
Gabrielli L, Sitges M, Chiong M, Jalil J, Ocaranza M, Llevaneras S, Herrera S, Fernandez R, Saavedra R, Yañez F, Vergara L, Diaz A, Lavandero S, Castro P
13
Ago
Protection of the myocardium against ischemia/reperfusion injury by angiotensin-(1-9) through an AT2R and Akt-dependent mechanism Pharmacol Res.
Evelyn Mendoza Torresa, Jaime A. Riquelme, Alejandra Vielma, Andrea Ramirez Sagredo, Luigi Gabrielli, Roberto Bravo Sagua, Jorge E. Jalil, Beverly A. Rothermel, Gina Sanchez, Maria Paz Ocaranza, Sergio Lavandero
13
Ago
Increased active phase atrial contraction is related to marathon runner performance European Journal of Applied Physiolog
Luigi Gabrielli, Sebastián Herrera, Felipe Contreras Briceño, Julián Vega, María Paz Ocaranza, Fernando Yáñez, Rodrigo Fernández, Rodrigo Saavedra, Marta Sitges, Lorena García, Mario Chiong, Sergio Lavandero, Pablo F. Castro
13
Ago
Angiotensin-(1-9) reduces cardiovascular and renal inflammation in experimental renin-independent hypertension. Biochem Pharmacol
Gonzalez L, Novoa U, Moya J, Gabrielli L, Jalil JE, García L, Chiong M, Lavandero S, Ocaranza MP.
13
Ago
Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: evolution toward prospective theranostic approaches. Theranostics.
Bejarano J, Navarro Marquez M, Morales Zavala F, Morales JO, Garcia Carvajal I, Araya Fuentes E, Flores Y, Verdejo HE, Castro PF, Lavandero S, Kogan MJ
06
Ago
Autophagy and oxidative stress in non-communicable diseases: A matter of the inflammatory state?
Peña Oyarzun D, BravoSagua R, Diaz-Vega A, Aleman L, Chiong M, Garcia L, Bambs C, Troncoso R, Cifuentes M, Morselli E, Ferreccio C, Quest AFG, Criollo A, Lavandero S